These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33709014)

  • 1. Single Protein Encapsulated Doxorubicin as an Efficacious Anticancer Therapeutic.
    Yu C; Huang F; Chow WA; Cook-Wiens G; Cui X
    Adv Ther (Weinh); 2020 Nov; 3(11):. PubMed ID: 33709014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Protein Encapsulated SN38 for Tumor-Targeting Treatment.
    Yu CJ; Huang F; Wang K; Liu M; Chow WA; Ling X; Li F; Causey JL; Huang X; Cook-Wiens G; Cui X
    Res Sq; 2023 Jul; ():. PubMed ID: 37546894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy.
    Arzt M; Gao B; Mozneb M; Pohlman S; Cejas RB; Liu Q; Huang F; Yu C; Zhang Y; Fan X; Jenkins A; Giuliano AE; Burridge PW; Cui X; Sharma A
    Stem Cell Reports; 2023 Oct; 18(10):1913-1924. PubMed ID: 37657447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
    Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
    Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
    Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
    Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
    Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
    Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors.
    Kinoshita R; Ishima Y; Chuang VTG; Watanabe H; Shimizu T; Ando H; Okuhira K; Otagiri M; Ishida T; Maruyama T
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSA-based multi-target combination therapy: regulating drugs' release from HSA and overcoming single drug resistance in a breast cancer model.
    Gou Y; Zhang Z; Li D; Zhao L; Cai M; Sun Z; Li Y; Zhang Y; Khan H; Sun H; Wang T; Liang H; Yang F
    Drug Deliv; 2018 Nov; 25(1):321-329. PubMed ID: 29350051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopic and cytotoxicity studies on the combined interaction of (-)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin.
    Guo Q; Liu M; Zhao Y; Wu Y; Liu J; Cai C; Shi Y; Han J
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Nov; 222():117213. PubMed ID: 31177010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor.
    Prakash J; Beljaars L; Harapanahalli AK; Zeinstra-Smith M; de Jager-Krikken A; Hessing M; Steen H; Poelstra K
    Int J Cancer; 2010 Apr; 126(8):1966-1981. PubMed ID: 19795464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy.
    Gabizon A; Ohana P; Amitay Y; Gorin J; Tzemach D; Mak L; Shmeeda H
    Cancer Drug Resist; 2021; 4(2):463-484. PubMed ID: 35582027
    [No Abstract]   [Full Text] [Related]  

  • 12. Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma.
    Kumbham S; Paul M; Itoo A; Ghosh B; Biswas S
    Int J Pharm; 2022 Feb; 614():121479. PubMed ID: 35041911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyapatite-binding albumin nanoclusters for enhancing bone tumor chemotherapy.
    Kang NW; Lee JY; Kim DD
    J Control Release; 2022 Feb; 342():111-121. PubMed ID: 34990700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-triggered drug-release vehicles for synergistic cancer therapy.
    Tu TY; Yang SJ; Tsai MH; Wang CH; Lee SY; Young TH; Shieh MJ
    Colloids Surf B Biointerfaces; 2019 Jan; 173():788-797. PubMed ID: 30384276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.
    Novais MVM; Gomes ER; Miranda MC; Silva JO; Gomes DA; Braga FC; Pádua RM; Oliveira MC
    Biomed Pharmacother; 2021 Apr; 136():111123. PubMed ID: 33486211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects.
    Lages EB; Fernandes RS; Andrade MMS; Paiyabhroma N; de Oliveira RB; Fernandes C; Cassali GD; Sicard P; Richard S; Branco de Barros AL; Ferreira LAM
    Biomed Pharmacother; 2021 Dec; 144():112373. PubMed ID: 34794238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth.
    Zhang D; Xu Q; Wang N; Yang Y; Liu J; Yu G; Yang X; Xu H; Wang H
    Int J Nanomedicine; 2018; 13():4549-4561. PubMed ID: 30127606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD19 mAb-conjugated human serum albumin nanoparticles effectively deliver doxorubicin to B-lymphoblastic leukemia cells.
    Pan H; Li S; Li M; Tao Q; Jia J; Li W; Wang L; Guo Z; Ma K; Liu Y; Cui C
    Pharmazie; 2020 Jul; 75(7):318-323. PubMed ID: 32635973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy.
    Zhu Q; Jia L; Gao Z; Wang C; Jiang H; Zhang J; Dong L
    Mol Pharm; 2014 Oct; 11(10):3269-78. PubMed ID: 24735448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging the Gap between Macroscale Drug Delivery Systems and Nanomedicines: A Nanoparticle-Assembled Thermosensitive Hydrogel for Peritumoral Chemotherapy.
    Huang P; Song H; Zhang Y; Liu J; Zhang J; Wang W; Liu J; Li C; Kong D
    ACS Appl Mater Interfaces; 2016 Nov; 8(43):29323-29333. PubMed ID: 27731617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.